SCLC Paradigm Advances With Immunotherapy, Integration of Rapid Research Autopsies
Published: Monday, Mar 23, 2020
Hui-Zi Chen, MD, PhD
The use of immunotherapy has led to a paradigm shift in the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC), but unmet needs remain, according to Hui-Zi Chen, MD, PhD.
... to read the full story